Status:
COMPLETED
Antibiotics Use and Carriage of Methicillin-resistant Staphylococci in Community Patients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Methicillin Resistant Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Brief Summary
In this prospective, observational, multicentric open study, the investigators will compare the acquisition rates of methicillin-resistant staphylococci (coagulase-negative staphylococci and Staphyloc...
Detailed Description
Rationale: Recent spread of community-acquired, methicillin-resistant Staphylococcus aureus (CA-MRSA) represents a major Public Health concern. MR coagulase-negative staphylococci (MR-CoNS) are a like...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age older than 18
- Prescription by a General Practitioner (investigator) of a β-lactam (amoxicillin-clavulanate or penicillins M), a macrolide, a synergistin or a fluoroquinolone for a minimal expected duration of 5 days (whatever the indication)
- Informed consent to the study protocol
- NON-INCLUSION CRITERIA:
- Hospitalization within the previous 6 months
- Antibiotherapy within the previous 2 months
- Combination antibiotherapy
- EXCLUSION CRITERIA:
- Prescription of a second-line antibiotherapy after inclusion
- Withdrawal of informed consent
Exclusion
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
571 Patients enrolled
Trial Details
Trial ID
NCT01489878
Start Date
March 1 2010
End Date
May 1 2012
Last Update
January 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bichat-Claude Bernard teaching hospital (AP-HP) and Xavier Bichat medical school (Denis Diderot - Paris 7 university)
Paris, France, 75018